Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abducens nerve paralysis
acute disseminated encephalomyelitis
acute disseminated encephalomyelitis, multiphasic
adenylate kinase 5 autoantibodies
advances in neurology
afebrile
affect, flat
aggression
agitation
alternative medicine
alveolar hypoventilation
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, preclinical
amnesia
amnesia, anterograde
amygdala
amygdalohippocampectomy
amyloid beta protein
amyloid imaging
amyloid plaques
ANA
angiography, cerebral
anti Hu antibody
anti Ro antibody
anticonvulsants
anticonvulsants, effectiveness
anticonvulsants, selection of
anticonvulsants, untoward effects of
antiviral agents
anxiety
aphasia
apolipoprotein E
arrhythmia, cardiac
arteriovenous malformation
arteriovenous malformation, cerebral
astrocytoma
asymptomatic
ataxia
ataxia, cerebellar
atypical
aura
autism
autoantibodies
autoimmune cerebellar ataxia
autoimmune disease
autoimmune GFAP astrocytopathy
automatisms
autonomic dysfunction
B cell lymphoma
Babinski sign
barbiturate anesthesia
basal ganglia
basal ganglia, lesion of
behavior
behavior, combative
behavioral disorder
biologic markers
blindness
blindness, sudden
brain atrophy
brain biopsy
brain volume
brainstem, lesion of
burst suppression pattern, electroencephalogram
carcinoma
carcinoma of lung
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, false negative
CAT scan, metrizamide
cavernous hemangioma
CD19-directed chimeric antigen receptor T-cell therapy
central nervous system, infection of
cerebellar lesion
cerebellar pontine angle
cerebellar pontine angle tumor
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral cortex
cerebral cortical atrophy
cerebral edema
cerebral edema, vasogenic
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
chemotherapy, CNS treatment and complications with
children
Clinical Pathologic Conference(C.P.C.)
cognition
coma
coma, medically induced
complications
confusion
confusional state, acute
corpus callosotomy
corpus callosum
corpus callosum, lesion of
cortical dysplasia, focal
cortical resection
cost effectiveness
cytokine release syndrome
cytomegalovirus infection
deep gray nuclei
degenerative diseases of CNS
delusion
dementia
dementia, diagnostic evaluation of
dementia, early detection
dementia, frontotemporal
dementia, rapidly progressive
dementia, screening for
demyelinating disease
diagnostic criteria
diarrhea
diet
differential diagnosis
diplopia
disability, neurological
disorientation
drowsiness
dysarthria
dyskinesia
dyskinesia, buccal lingual facial
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electroencephalogram, periodic complexes
electroencephalogram, video monitoring with
encephalitis
encephalitis, autoimmune
encephalitis, focal
encephalitis, unknown etiology
encephalitis, viral
encephalomalacia
encephalomyelitis
encephalopathy
encephalopathy, acute
encephalopathy, limbic
encephalopathy, post traumatic
epilepsy
epilepsy monitoring unit
epileptic encephalopathy
episodic disorders
episodic neurologic deficits
eye movement, disorders of
face, numbness of
facial asymmetry
facial weakness
familial
febrile infection-related epilepsy syndrome
fever
flu-like illness
gammaglobulin therapy, intravenous
gender
Geschwind, Norman
GFAP-IgG
glioma
gliomatosis cerebri
gliosis
glutamic acid decarboxylase, antibody
glyphosate
gray matter
hallucination
hallucination, auditory
hamartoma
head injury
head injury, prognosis in
headache
headache, recurrent
hemimyoclonic jerks
hemiparesis
hemispherectomy
heralding manifestation
herbicide
herpes simplex encephalitis
hiccoughs
hippocampal atrophy
hippocampus
hippocampus, hyperintense
histopathology
human herpesvirus 6
hyperactivity
hypersomnia
hyponatremia
hypothalamus, lesion of
hypothyroidism
immune effector cell-associated neurotoxicity syndrome
immune-related adverse events
immunohistochemistry
immunologic disease
immunosuppression
immunosuppressive agents
immunotherapy
inattention
incidentaloma
inclusion bodies
inclusion bodies, intracytopasmic
infection
insular cortex
insular cortex, lesion
insular cortex, lesion, bilateral
intellectual deficit
intellectual deterioration
ketogenic diet
learning disability
learning disability, in children
lethargy
leucine rich glioma inactivated 1 antibodies
leukopenia
level of consciousness
level of consciousness, decreased
limbic encephalitis
limbic system
limbic-predominant age-related TDP-43 encephalopathy
lobar atrophy
lymphadenopathy, hilar
lymphoma
lymphoma, systemic
malformation, vascular
malformation, vascular, cerebral
malignancy screen
memory, defect of recent
memory, evaluation of
memory, impairment of
meningeal enhancement
meningioma
meningitis
meningitis, neurologic aspects and complications of
meningitis, seizures with
meningoencephalomyelitis
mental retardation
mesial temporal lobe
mesial temporal lobe epilepsy
mesial temporal sclerosis
mesial temporal sclerosis, bilateral
microhemorrhage, intracerebral
microinfarcts
midbrain, lesion of
middle cerebellar peduncle, lesion
mild cognitive impairment
mimics
misdiagnosis
mitochondrial disease
mortality
movement disorder
MRI
MRI pattern
MRI, abnormal
MRI, abnormal, seizure causing
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, disappearing lesion on
MRI, false negative
MRI, field strength, high
MRI, FLAIR
MRI, functional
MRI, gyral enhancement
MRI, head injury
MRI, incidental finding
MRI, indications for
MRI, morphometyry
MRI, negative
MRI, ring sign
MRI, ring sign, open
MRI, serial
MRI, spinal cord
MRI, volumetry
MRI, voxel-based morphometry
MRS
multiple sclerosis
multiple sclerosis, misdiagnosis
multiple subpial transection
myelitis, longitudinal
myoclonic jerks
myoclonus
negative
neoplasm, primary intracerebral
neoplasm, primary intracranial
neoplasm, primary of CNS
neoplasm, primary of CNS-children
neurologic disease, diagnoses of
neuromyelitis optica (Devic's disease)
neuromyelitis optica spectrum disorder
neuronal migration disorder
neuropathology
neuropathology, brain
neuropathy
neurosyphilis
neurotoxin
NMDA antagonists
NMDA receptors
normal
nystagmus
nystagmus, primary position of gaze
ocular dipping
old age, neurology of
optic chiasm
optic chiasm, lesion of
pain
pain, leg
pallor
paranoia
Parkinsonism syndrome
periaqueductal lesion
perseveration
personality change
personality disorder
plasmapheresis
PLEDs
PLEDs, bilateral independent
PLEDs, etiology of
pleocytosis of cerebrospinal fluid
posterior fossa, lesion of
postictal neurologic deficits
postictal psychosis
potassium channel antibodies
precipitating factors
preclinical
prevention of neurologic disorders
prognosis
progressive neurologic disorder
prosopagnosia
psychiatric problems in neurologic disorders
psychological testing
psychosis
psychosurgery
psychotic behavior
pulmonary nodules
quadrantanopsia, superior
quadriparesis
rapidly progressing neurologic illness
recurrent
release phenomena
religiosity
remote effect of cancer on the nervous system
reversible neurologic disorder
review article
rheumatoid arthritis factor(R.A.factor)
risk factors
salivation, excessive
schizophrenia
screening
sedimentation rate, elevated
seizure
seizure, adult onset
seizure, children
seizure, classification of
seizure, complications following
seizure, diagnosis of
seizure, drug resistance
seizure, elderly
seizure, equivalents
seizure, etiology of
seizure, febrile
seizure, febrile, risk of epilepsy following
seizure, focal
seizure, focus
seizure, intractable
seizure, intractable, treatment of
seizure, medication failure
seizure, new onset
seizure, prevention of
seizure, prognosis in adults
seizure, prognosis in childhood
seizure, psychomotor-frontal lobe
seizure, psychomotor-temporal lobe
seizure, psychomotor-temporal lobe, interictal behavior
seizure, psychomotor-temporal lobe, prognosis of
seizure, psychosocial aspects of
seizure, recurrent
seizure, risk factors for
seizure, surgical treatment of
seizure, treatment of
seizure, treatment of, polytherapy
seizure, treatment, adjunctive therapy
seizure, workup of
serologic testing
serologic testing of cerebrospinal fluid
seronegative
sexual behavior, disorder of
single photon emission computed tomography
Sjogren's syndrome
Sjogren's syndrome, neurologic manifestations of
sleep
small vessel disease
speech disorder
speech, slowed
standing difficulty
stare
status epilepticus
status epilepticus, intractable
steroid therapy, CNS treatment and complications with
stimulation, deep brain
subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease
subacute sclerosing panencephalitis, adult onset
subinsular cortex
symmetric brain lesions
syphilis, diagnosis and treatment
syphilis, neurologic complications with
tau protein
TDP-43 proteinopathy
temporal horn, enlarged
temporal lobe
temporal lobe, atrophy
temporal lobe, lesion
temporal lobe, lesion, bilateral
temporal lobe, status
temporal lobe, tumor
temporal lobectomy
temporal lobectomy, complications
teratoma
teratoma, ovarian
thalamus, lesion of
thyroid function tests
thyroiditis
tonic spasms
toxic encephalopathy
transient neurologic deficit
treatment of neurologic disorder
tremor
tuberous sclerosis
vaccination, neurologic complications with
vagus nerve stimulation
vasculopathy
ventricular enlargement
violent behavior
viral infection, CNS
visual field defect
visual loss
visual loss, sudden
water channel antibodies
weight loss
whistling
white matter disease
word-finding difficulty
workup
Showing articles 350 to 400 of 2500 << Previous Next >>

Mycophenolate Mofetil in Multiple Sclerosis: A Multicentre Retrospective Study on 344 Patients
JNNP 85:279-283,246, Michel, L.,et al, 2014

Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014

Enterovirus Vaccines for an Emerging Cause of Brain-Stem Encephalitis
NEJM 370:792-794, McMinn, P.C., 2014

Relapsing-Remitting Tumefactive Demyelination
JAMA Neurol 71:366-367, Brandao, E.,et al, 2014

Daclizumab-Induced Adverse Events in Multiple Organ Systems in Multiple Sclerosis
Neurol 82:984-988, Oh, J.,et al, 2014

Summary of Evidence-Based Guideline: Complementary and Alternative Medicine in Multiple Sclerosis
Neurol 82:1083-1092, Yadav, V.,et al, 2014

Complementary and Alternative Medicine in Multiple Sclerosis
Neurol 82:e103-e104, Fox, R.J., 2014

Effect of high-dose Simvastatin on Brain Atrophy and Disability in Secondary Progressive Multiple Sclerosis (MS-STAT): A Randomised, Placebo-Controlled, Phase 2 Trial
Lancet 383:2213-2221, Chataway, J.,et al, 2014

Recommendations for the Management of Cerebral and Cerebellar Infarction with Swelling
Stroke 45:1222-1238, Wijdicks, E.F.M.,et al, 2014

Hemicraniectomy in Older Patients with Extensive Middle-Cerebral-Artery Stroke
NEJM 370:1091-1100,1159, Juttler, E.,et al, 2014

ICU-Acquired Weakness and Recovery from Critical Illness
NEJM 370:1626-1635, Kress, J.P. & Hall, J.B., 2014

Superficial Abdominal Reflex
NEJM 370:e29, Baden, L.R., 2014

Should Doctors Prescribe Cannabinoids?
BMJ 348:g2737, Farrell, M.,et al, 2014

Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014

Venous Thromboembolism in Amyotrophic Lateral Sclerosis
Neurol 82:1674-1677, Gladman, M.,et al, 2014

Intensive Care Unit Admission in Multiple Sclerosis
Neurol 82:2112-2119, Marrie, R.A.,et al, 2014

Balos Concentric Sclerosis
Lancet Neurol 13:740-746, Hardy, T.A. & Miller, D.H., 2014

The Etiology of Ring Lesions on Diffusion-Weighted Imaging
NeuroRadiol J 27:280-287, Finelli, P. & Foxman, E.B., 2014

IgG4-Related Hypertrophic Pachymeningitis
JAMA Neurol 71:785-793, Lu, L.X.,et al, 2014

Palliative Care and Neurology
Neurol 83:561-567, Boersma, I.,et al, 2014

The Management of Spasticity in Adults
BMJ 349:g4737, Nair, K.P.S. & Marsden, J., 2014

Amyloid-Beta Related Angiitis of the Central Nervous System: Case Report and Topic Review
Front Neurol 5:1-4, Nouh, A.,et al, 2014

Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014

Herpes Simplex Virus Encephalitis:Clinical Manifestations,Diagnosis and Outcome in 106 Adult Patients
J Clin Virol 60:112-118, Sili,U.,et al, 2014

Degenerative Diseases of the Nervous System, Amyotrophic Lateral Sclerosis
Adams & Victors Principles of Neurology, Chp 39, pg 1109, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Progressive Muscle Atrophy
Adams & Victors Principles of Neurology, Chp 39, pg 1111, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Progressive Bulbar Palsy
Adams & Victors Principles of Neurology, Chp 39, pg 1111, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Werdnig-Hoffman Disease, Spinal Muscular Atrophy
Adams & Victors Principles of Neurology, Chp 39, pg 1116, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Kugelberg-Welander Syndrome SMAIII
Adams & Victors Principles of Neurology, Chp 39, pg 1118, Ropper, A.H.,et al, 2014

Cerebral Venous Thrombosis after High Dose Steroid in Multiple Sclerosis: A Case Report
Hippokratia 17:88-90, Gazioglu, S.,et al, 2013

Central Nervous System Involvement in Whipple Disease
Medicine 92:324-330, Compain, C.,et al, 2013

Tumefactive MS Lesions under Fingolimod
Neurol 81:1654-1658, Pilz, G.,et al, 2013

Longitudinally Extensive Transverse Myelitis with and Without Aquaporin 4 Antibodies
JAMA Neurol 70:1375-1381, Kitley, J.,et al, 2013

Macroglossia in Amyotrophic Lateral Sclerosis
JAMA Neurol 70:1432-1435, McKee, H.R.,et al, 2013

An Expanded Role for Neuroimaging in the Evaluation of Memory Impairment
AJNR 34:2075-2082, Desikan, R.S.,et al, 2013

Clinical Features of MS Associated with Leber Hereditary Optic Neuropathy mtDNA Mutations
Neurol 81:2073-2081, Pfeffer, G.,et al, 2013

Three Times Weekly Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
Ann Neurol 73:705-713, Khan, O.,et al, 2013

Interdependence and Contributions of Sun Exposure and Vitamin D to MRI Measures in Multiple Sclerosis
JNNP 84:1075-1081, 1066, Zivadinov, R.,et al, 2013

Subacute Sclerosing Panencephalitis
www.MedLink.com, February, Auwaeter,P.G.&Johnson,R.T., 2013

Everolimus Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Ann Neurol 74:679-687, Krueger, D.A.,et al, 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200,2176, Maringer, R.,et al, 2013

Aquaporin-4 Antibody-Positive Cases Beyond Current Diagnosis Criteria for NMO Spectrum Disorders
Neurol 80:2210-2216, Sato, D.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013

Clinicopathologic Conference, Oligoastrocytoma, Grade II with Temporal-Lobe Seizure and Ictal Asystole (Arrhythmogenic Epilepsy)
NEJM 368:2304-2312, Case 18-2013, 2013

Brain Abnormalities as an Initial Manifestation of Neuromyelitis Optica Spectrum Disorder
MSJ 17:1107-1112, Kim, W.,et al, 2013

Clinical Spectrum of CNS Aquaporin-4 Autoimmunity
Neurol 78:1179-1185, Kim, S.,et al, 2013

Differential Diagnosis of Neuromyelitis Optica Spectrum Disorders
Brain Neurol 62:953-960, Tanaka, T., 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200, 2176, Marignier, R.,et al, 2013

Characterising Aggressive Multiple Sclerosis
JNNP doi:10.1136 1-7, Menon, S.,et al, 2013

Spinal Cord Lesions in Patients with Clinically Isolated Syndrome
Neurol 80:69-75, Sombekke, M.,et al, 2013



Showing articles 350 to 400 of 2500 << Previous Next >>